Attached files

file filename
10-K - FORM 10-K - Seagen Inc.d10k.htm
EX-31.1 - SECTION 302 CERTIFICATION - Seagen Inc.dex311.htm
EX-32.1 - SECTION 906 CERTIFICATION - Seagen Inc.dex321.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Seagen Inc.dex231.htm
EX-31.2 - SECTION 302 CERTIFICATION - Seagen Inc.dex312.htm
EX-10.44 - EMPLOYMENT AGREEEMENT - Seagen Inc.dex1044.htm
EX-10.49 - AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENT - Seagen Inc.dex1049.htm
EX-10.50 - COLLABORATION AGREEMENT - Seagen Inc.dex1050.htm
EX-10.48 - COMPENSATION INFORMATION FOR EXECUTIVE OFFICERS AND DIRECTORS - Seagen Inc.dex1048.htm
EX-10.43 - EMPLOYMENT AGREEMENT - Seagen Inc.dex1043.htm
EX-10.13 - 2000 DIRECTORS' STOCK OPTION PLAN - Seagen Inc.dex1013.htm
EX-10.51 - LONG TERM INCENTIVE PLAN - Seagen Inc.dex1051.htm

Exhibit 32.2

 

SEATTLE GENETICS, INC.

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Seattle Genetics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd E. Simpson, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

 

  (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/    TODD E. SIMPSON        

Todd E. Simpson

Chief Financial Officer

March 12, 2010

 

This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Seattle Genetics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.